< 1 minute read
Oct. 6, 2021
Compound 4f: A MAGL Inhibitor
"compound 4f"
oral, brain-penetrant, reversible MAGL inh. in vivo PK/PD in CNS (0.3-10 mpk PO) from HTS and SBDD Journal of Medicinal Chemistry Takeda, Fujisawa, Japan
Loading...
oral, brain-penetrant, reversible MAGL inh. in vivo PK/PD in CNS (0.3-10 mpk PO) from HTS and SBDD Journal of Medicinal Chemistry Takeda, Fujisawa, Japan